• Skip to primary navigation
  • Skip to main content
  • Skip to primary sidebar
  • Skip to footer
  • Advertise
  • Subscribe

MassDevice

The Medical Device Business Journal — Medical Device News & Articles | MassDevice

  • Latest News
  • Technologies
    • Artificial Intelligence (AI)
    • Cardiovascular
    • Orthopedics
    • Neurological
    • Diabetes
    • Surgical Robotics
  • Business & Finance
    • Wall Street Beat
    • Earnings Reports
    • Funding Roundup
    • Mergers & Acquisitions
    • Initial Public Offering (IPO)
    • Legal News
    • Personnel Moves
    • Medtech 100 Stock Index
  • Regulatory & Compliance
    • Food & Drug Administration (FDA)
    • Recalls
    • 510(k)
    • Pre-Market Approval (PMA)
    • MDSAP
    • Clinical Trials
  • Special Content
    • Special Reports
    • In-Depth Coverage
    • DeviceTalks
  • Podcasts
    • MassDevice Fast Five
    • DeviceTalks Weekly
    • OEM Talks
      • AbbottTalks
      • Boston ScientificTalks
      • DeviceTalks AI
      • IntuitiveTalks
      • MedtechWOMEN Talks
      • MedtronicTalks
      • Neuro Innovation Talks
      • Ortho Innovation Talks
      • Structural Heart Talks
      • StrykerTalks
  • Resources
    • About MassDevice
    • DeviceTalks
    • Newsletter Signup
    • Leadership in Medtech
    • Manufacturers & Suppliers Search
    • MedTech100 Index
    • Videos
    • Webinars
    • Whitepapers
    • Voices
Home » Metal hip developer deposed in ongoing DePuy lawsuit | Legal News

Metal hip developer deposed in ongoing DePuy lawsuit | Legal News

March 13, 2012 By MassDevice staff

gavel

 DePuy ASR hip developer deposed for questioning

Dr. Thomas Schmalzried, 1 of the primary developers of the troubled ASR hip implants DePuy Orthopaedics recalled last year, was deposed for questioning alongside a group of executives from the Johnson & Johnson (NYSE:JNJ) subsidiary as part of ongoing legal proceedings against the device maker.

Schmalzried, a consultant for DePuy, took home more than $2.4 million in "royalty income for intellectual property and/or product development" in 2010 and 2011, according to DePuy’s website.

The lawsuit accuses him of assisting in DePuy’s marketing efforts, promoting the devices to his peers and publishing papers that were later used by DePuy sales teams to defer safety concerns raised by other orthopedic surgeons, according to a press release.

Further depositions are slated for March to May. Those deposed have been asked to produce documents, notes, outlines, presentation materials, testimonies and oral proposals related to the case, according to the release.

Schmalzried joins a clutch of DePuy executives, including the company’s director of strategic engineering, vice president of regulatory affairs and vice president of worldwide clinical affairs, in being deposed for the lawsuit. Legal eagles expect the recall to become the costliest ever, potentially reaching the $1 billion mark. Read more

Read more medical device legal news from MassDevice.com

 New Jersey fund wants J&J to reimburse for faulty hips
A New Jersey-based employee benefits fund sued Johnson & Johnson, asking the court to reimburse insurers and 3rd-party payors for money spent on DePuy hip implants. Read more

 Masimo affirms 1st-inventor status for oximetry technology
A Federal Circuit court affirmed Masimo’s (NSDQ:MASI) status as the 1st inventor of measure-through-motion pulse oximetry technology.  Read more

 What does Smith & Nephew’s $22.2M DOJ settlement mean for the device industry?
Smith & Nephew (NYSE:SNN) $22.2 million settlement for breaches of the Foreign Corrupt Practices Act may mark a significant shift in the medical devices industry. Read more

Filed Under: News Well, Recalls Tagged With: depuysynthes, Hips, Johnson and Johnson, Legal Roundup, Masimo, Smith & Nephew, U.S. Justice Dept. (DOJ)

More recent news

  • Medtronic escapes $106.5M payment in Colibri TAVR patent suit after court overturns jury verdict
  • RadNet closes iCAD acquisition, expands AI breast‑imaging portfolio
  • Hyperfine reports first commercial sales of next-gen AI-powered Swoop
  • Stereotaxis announces $12.5M offering
  • Nuwellis ends clinical trial of its ultrafiltration tech for heart failure

Primary Sidebar

“md
EXPAND YOUR KNOWLEDGE AND STAY CONNECTED
Get the latest med device regulatory, business and technology news.

DeviceTalks Weekly

See More >

MEDTECH 100 Stock INDEX

Medtech 100 logo
Market Summary > Current Price
The MedTech 100 is a financial index calculated using the BIG100 companies covered in Medical Design and Outsourcing.
MDO ad

Footer

MASSDEVICE MEDICAL NETWORK

DeviceTalks
Drug Delivery Business News
Medical Design & Outsourcing
Medical Tubing + Extrusion
Drug Discovery & Development
Pharmaceutical Processing World
MedTech 100 Index
R&D World
Medical Design Sourcing

DeviceTalks Webinars, Podcasts, & Discussions

Attend our Monthly Webinars
Listen to our Weekly Podcasts
Join our DeviceTalks Tuesdays Discussion

MASSDEVICE

Subscribe to MassDevice E-Newsletter
Advertise with us
About
Contact us

Copyright © 2025 · WTWH Media LLC and its licensors. All rights reserved.
The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of WTWH Media.

Privacy Policy